Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
P N G Med J ; 44(1-2): 6-16, 2001.
Article in English | MEDLINE | ID: mdl-12418673

ABSTRACT

BACKGROUND: In view of high mortality and morbidity from Haemophilus influenzae type b (Hib) in young Papua New Guinean children, the incorporation of a Hib conjugate vaccine into a nationwide immunization program would be of major public health benefit. METHODS: We evaluated the safety and immunogenicity of a lyophilized and a liquid form of Hib polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given in the same syringe as diphtheria-tetanus-pertussis (DTP) vaccine to children in Goroka, Eastern Highlands Province. In Part 1 of the study 209 children were randomized to receive at ages 1, 2 and 3 months either DTP alone or a liquid formulation of DTP/PRP-T or lyophilized PRP-T dissolved in DTP suspension. A further 75 children were given the liquid DTP/PRP-T formulation at ages 2, 3 and 4 months (Part 2). 54 children aged 15-18 months were given a booster of the same preparation of PRP-T/DTP as they had received during Part 1. Blood for antibody assays was collected at enrolment, before (Part 1 only) and one month after the third dose, then just before and 3 weeks after the booster dose. RESULTS: Follow-up to age of 12 months showed that PRP-T was safe with no evidence of impaired response to individual vaccine components when combined with DTP. Geometric mean titres (GMTs) of anti-PRP antibody before vaccination (n = 64, mean age 41 days), after 2 doses (mean age 99 days) and after 3 doses (mean age 132 days) of the lyophilized formulation were 0.21, 1.48 and 5.04 microg/ml, respectively, with 58% and 89% having anti-PRP antibody titres > or = 1.0 microg/ml after 2 and 3 doses, respectively. Anti-PRP antibody responses to the liquid Hib vaccine formulation were lower (GMT post-dose 3 = 0.48 microg/ml) than to the lyophilized formulation, but better responses were elicited from older children (Part 2; GMT post-dose 3 = 0.78 microg/ml, with 79% > or = 0.15 microg/ml). Both PRP-T preparations elicited excellent booster responses suggesting that children are likely to be protected if exposed to Hib infection. CONCLUSIONS: Lyophilized PRP-T given together with DTP is safe and immunogenic when given to young infants. The liquid DTP/PRP-T formulation showed a lower immunogenicity than in earlier studies with this vaccine, which might have been due to exposure to low temperature during shipment or the younger age at immunization.


Subject(s)
Diphtheria-Tetanus-Pertussis Vaccine/administration & dosage , Haemophilus Infections/immunology , Haemophilus Infections/prevention & control , Haemophilus Vaccines/administration & dosage , Immunization Schedule , Tetanus Toxoid/administration & dosage , Vaccination/methods , Administration, Oral , Analysis of Variance , Chi-Square Distribution , Child, Preschool , Dose-Response Relationship, Drug , Female , Humans , Immunity/physiology , Immunization, Secondary/methods , Infant , Infant, Newborn , Injections, Intramuscular , Male , Papua New Guinea , Safety , Sensitivity and Specificity
2.
Trans R Soc Trop Med Hyg ; 93(2): 214-9, 1999.
Article in English | MEDLINE | ID: mdl-10450452

ABSTRACT

This trial confirmed the immunogenicity of a standard dose of measles vaccine Edmonston-Zagreb strain administered at the age of 6 months as evaluated serologically at 12 months of age in 94 healthy children in Saudi Arabia. The residual seropositivity rate for measles was 53.4 and 80.6% as measured by enzyme immunoassay (EIA) and plaque neutralization, respectively, and could be increased to virtually 100% seroprotection after immunization with 1 of 2 measles-mumps-rubella (MMR) vaccines (Triviraten Berna or MMR II MSD) at 12 months of age. In both groups, more than 90% of infants showed an immune response to the mumps and rubella vaccine strains at 14 months of age. There was a difference in the geometric mean titres of mumps antibodies in favour of MMR II (P < 0.001). The seroconversion rates for mumps antibodies differed between the 2 vaccines because of the different test systems and/or the different cut-off levels used. The study reconfirmed that for the assessment of Rubini mumps vaccine-induced antibodies the indirect immunofluorescence test is superior to the EIA. The systemic tolerability of both vaccines was excellent. Triviraten Berna is exclusively propagated on human diploid cell cultures and hence free of avian proteins.


Subject(s)
Measles Vaccine/immunology , Mumps Vaccine/immunology , Rubella Vaccine/immunology , Antibodies, Viral/biosynthesis , Humans , Immunoenzyme Techniques , Infant , Measles-Mumps-Rubella Vaccine , Neutralization Tests , Saudi Arabia , Time Factors , Vaccines, Combined/immunology
3.
Infect Immun ; 67(7): 3680-5, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10377160

ABSTRACT

The mucosal and systemic immune responses after primary and booster immunizations with two attenuated live oral vaccine strains derived from a noninvasive (Vibrio cholerae) and an invasive (Salmonella typhi) enteric pathogen were comparatively evaluated. Vaccination with S. typhi Ty21a elicited antibody-secreting cell (ASC) responses specific for S. typhi O9, 12 lipopolysaccharide (LPS), as well as significant increases in levels of immunoglobulin G (IgG) and IgA antibodies to the same antigen in serum. A strong systemic CD4(+) T-helper type 1 cell-mediated immune (CMI) response was also induced. In contrast to results with Ty21a, no evidence of a CMI response was obtained after primary immunization with V. cholerae CVD 103-HgR in spite of the good immunogenicity of the vaccine. Volunteers who received a single dose of CVD 103-HgR primarily developed an IgM ASC response against whole vaccine cells and purified V. cholerae Inaba LPS, and seroconversion of serum vibriocidal antibodies occurred in four of five subjects. Serum IgG anti-cholera toxin antibody titers were of lower magnitude. For both live vaccines, the volunteers still presented significant local immunity 14 months after primary immunization, as revealed by the elevated baseline antibody titers at the time of the booster immunization and the lower ASC, serum IgG, and vibriocidal antibody responses after the booster immunization. These results suggest that local immunity may interfere with colonization of the gut by both vaccine strains at least up to 14 months after basis immunization. Interestingly, despite a low secondary ASC response, Ty21a was able to boost both humoral (anti-LPS systemic IgG and IgA) and CMI responses. Evidence of a CMI response was also observed for one of three volunteers given a cholera vaccine booster dose. The direct comparison of results with two attenuated live oral vaccine strains in human volunteers clearly showed that the capacity of the vaccine strain to colonize specific body compartments conditions the pattern of vaccine-induced immune responses.


Subject(s)
Antibodies, Bacterial/immunology , Antigens, Bacterial/immunology , Cholera Vaccines/immunology , Immunity, Mucosal , Immunity , Vibrio cholerae/immunology , Antibody Specificity , Humans , Immunization , Immunoglobulin Isotypes
4.
Wien Klin Wochenschr ; 110(10): 376-8, 1998 May 22.
Article in English | MEDLINE | ID: mdl-9654693

ABSTRACT

The goal of the present study was to evaluate the tolerability and acceptability of an oral cholera vaccine (CVD103HgR) in individuals preparing for travel to countries endemic for cholera. 2545 Austrian travelers between 6 months and 81.5 years of age received a single dose of CVD103HgR and were asked to complete a questionnaire for documentation of adverse events during a 7 day period post immunization. Events were recorded regardless of whether they were caused by concomitant vaccinations or other factors and thus, a causative relationship was not necessarily present. Despite this drawback and the possibility of overreporting this study has proven a low frequency in side effects and the good tolerability of CVD103HgR. Occasional gastrointestinal side effects (15% diarrhea, 8.1% nausea, 1.1% vomiting) were seen and were of mild character and probably a consequence of associated intake of sodium bicarbonate buffer. Other events (7% skin eruptions, 2.7% fever) were mild and considered as harmless (or not vaccine related). The results show that the oral cholera vaccine CVD103HgR was well tolerated and accepted by travelers.


Subject(s)
Cholera Vaccines/adverse effects , Cholera/prevention & control , Administration, Oral , Adolescent , Adult , Adverse Drug Reaction Reporting Systems , Aged , Aged, 80 and over , Antibodies, Bacterial/blood , Austria , Child , Child, Preschool , Cholera/immunology , Cholera Vaccines/administration & dosage , Cholera Vaccines/immunology , Female , Humans , Infant , Male , Middle Aged , Travel
6.
Appl Environ Microbiol ; 61(4): 1226-31, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7747945

ABSTRACT

We have developed a simple, fast, and efficient procedure to detect enteroviruses in water samples. Aliquots of water are subjected to two-step filtration, with the second filter containing a positively charged nylon membrane that holds back virus particles. Viruses thus adsorbed are directly lysed, and RNA is isolated by hybridization to specific oligonucleotides bound to magnetic beads. The solution used contains guanidine thiocyanate, which lyses virus particles, inactivates enzymes, e.g., RNases, allows mild hybridization conditions, and does not influence biotin-streptavidin interaction on magnetic beads. Detection and specific identification are accomplished by reverse transcription PCR of the highly conserved noncoding region at the 5' end of virus RNA combined with Southern hybridization. The system was tested with tap water artificially spiked with poliovirus vaccine and yielded a detection limit of 20 50% tissue culture infective doses per liter. We used the same procedure to investigate the water quality of surface water at public beaches by rivers and lakes. Of 40 samples tested, 7 were positive for enteroviruses. A comparison with enterobacterial contamination determined by PCR and classical microbiological methods in parallel showed that enteroviruses were found only in samples also positive for Escherichia coli. In conclusion, this procedure can easily be adapted to test large water samples and is simple enough to be used for routine determinations of water quality in terms of virus contamination.


Subject(s)
Enterovirus/genetics , Enterovirus/isolation & purification , Polymerase Chain Reaction/methods , Water Microbiology , Base Sequence , DNA Primers/genetics , DNA, Bacterial/genetics , DNA, Bacterial/isolation & purification , DNA, Viral/genetics , DNA, Viral/isolation & purification , Enterovirus Infections/prevention & control , Escherichia coli/genetics , Escherichia coli/isolation & purification , Evaluation Studies as Topic , Fresh Water , Humans , Molecular Sequence Data , Polymerase Chain Reaction/statistics & numerical data , Sensitivity and Specificity , Transcription, Genetic , Water Supply/standards
8.
Res Microbiol ; 146(1): 85-97, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7754231

ABSTRACT

The presence of pathogenic bacteria poses a serious problem in sustaining the safety of dairy products. Microbiological routine controls of these products make use of selective culture techniques. To detect pathogenic species, isolated colonies are characterized by specific metabolic activities and by serotyping. We present an alternative biochemical approach that does not require culture of bacteria. The total bacterial populations of food samples were isolated by centrifugation and analysed by PCRs specific for pathogenic species. A total of 90 raw milk samples and dairy products made from raw milk were screened by this method for the presence of Listeria monocytogenes, Escherichia coli, enterotoxigenic E. coli, Campylobacter jejuni and C. coli. Detection rates were 12/90 (13%) for L. monocytogenes, 41/90 (46%) for E. coli, 18/90 (20%) for enterotoxigenic E. coli producing heat-labile toxin type I or heat-stable toxin type I, and 6/90 (7%) for C. jejuni or C. coli. Except for the use of different amplification primers, this approach is identical for any bacterial species to be detected. Direct PCR analysis of food samples offers rapid screening for the presence of specific bacteria and enables selection of critical samples prior to culture.


Subject(s)
Campylobacter jejuni/isolation & purification , Dairy Products , Escherichia coli/isolation & purification , Listeria monocytogenes/isolation & purification , Milk , Animals , Campylobacter coli/isolation & purification , Electrophoresis, Agar Gel , Food Microbiology , In Vitro Techniques , Polymerase Chain Reaction/methods
9.
PCR Methods Appl ; 4(2): 117-23, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7580883

ABSTRACT

A major problem in the application of PCR is contamination with material amplified previously. Repeated PCRs result in the accumulation of intact and degraded amplicons and primer artifacts that can contaminate following amplification reactions. Post-PCR UV treatment and pre-PCR uracil DNA glycosylase (UDG) digestion have been recognized to efficiently inactivate or decompose intact amplification fragments. We show here that degraded amplification products and primer artifacts account for decreased sensitivity and may cause false-negative results. Our experiments indicate that partly degraded PCR products and primer artifacts containing sequences homologous to the primer oligonucleotides in the succeeding PCR reaction compete efficiently with sample DNA for the primers. The experiments done in this study may explain unexpectedly low PCR sensitivities reported in an increasing number of publications. In an attempt to solve this problem, we evaluated three post-PCR treatment methods to completely eliminate sequences competing for the amplification primers, namely, 8-methoxypsoralen (MOPS) or hydroxylamine treatment of amplified DNA and use of oligonucleotides containing 5'-ChemiClamps. However, all three methods did not sufficiently inhibit artificially produced carryover contaminations. In conclusion, false-positive results can be eliminated with UDG or UV treatment, but physical barriers are indispensable to avoid the occurrence of false-negative results.


Subject(s)
DNA Glycosylases , Decontamination/standards , Polymerase Chain Reaction/methods , Artifacts , Base Sequence , DNA Primers , Decontamination/instrumentation , False Negative Reactions , False Positive Reactions , Molecular Sequence Data , N-Glycosyl Hydrolases , Reproducibility of Results , Ultraviolet Rays , Uracil-DNA Glycosidase
10.
Appl Environ Microbiol ; 59(7): 2161-5, 1993 Jul.
Article in English | MEDLINE | ID: mdl-8357250

ABSTRACT

A polymerase chain reaction (PCR) method designed to sensitively detect and identify Campylobacter jejuni and Campylobacter coli without the need for isolating and culturing strains is described. The intergenic sequence between the flagellin genes flaA and flaB was amplified and characterized with a triple primer or seminested primer approach. A total of 50 bacterial strains, 27 of C. jejuni and C. coli and 23 of other species, were tested, giving no false-positive or false-negative results. The detection limit as determined by ethidium bromide staining of amplification products on agarose gels was 10 bacteria or less in artificially contaminated water, milk, and soft cheese samples with the seminested primer PCR assay. As an application of the PCR system, a set of 93 samples of milk and other dairy products was screened for the presence of C. jejuni and C. coli. We identified six positive samples (6.5%), while none were found with a conventional culture method.


Subject(s)
Campylobacter coli/isolation & purification , Campylobacter jejuni/isolation & purification , Dairy Products/microbiology , Milk/microbiology , Polymerase Chain Reaction/methods , Animals , Base Sequence , Campylobacter coli/genetics , Campylobacter jejuni/genetics , DNA, Bacterial/genetics , Molecular Sequence Data , Sensitivity and Specificity
11.
Biotechnology (N Y) ; 10(9): 1026-8, 1992 Sep.
Article in English | MEDLINE | ID: mdl-1368999

ABSTRACT

We describe a novel, versatile procedure for the light-dependent immobilization of ligands to 'inert' material surfaces. Covalent immobilization of ligands differing in chemical nature and complexity is accomplished under mild and non-destructive conditions. Topical interaction of ligands with organic or inorganic surfaces is mediated by photoactivable polymers with carbene generating trifluoromethyl-aryl-diazirines which serve as linker molecules. Light activation of aryl-diazirino functions at 350 nm yields highly reactive carbenes, and covalent coupling is achieved by simultaneous carbene insertion into both the ligand and inert surface. Thus, reactive functional groups are not required on either the ligand or the supporting material. These procedures are applicable whenever ligands, from molecules to cells--synthetically or genetically produced, or isolated from biological sources--need to be immobilized for improved performance.


Subject(s)
Azirines/chemistry , Biotechnology/methods , Light , Alkaline Phosphatase/chemistry , Bacterial Proteins/chemistry , Ligands , Photochemistry , Polystyrenes , Polyvinyls/chemistry , Streptavidin , Surface Properties
SELECTION OF CITATIONS
SEARCH DETAIL
...